PCSK9 inhibition ameliorates microplastic-induced endothelial redox imbalance via SIRT6 modulation

Nunzia D'Onofrio1,2, Isabella Donisi1, Vitale Del Vecchio3

  • 1Department of Precision Medicine, University of Campania Luigi Vanvitelli, Via L. De Crecchio 7, 80138, Naples, Italy.

PubMed
Abstract

Insights

Microplastics (MPs) harm vascular health by impairing endothelial cells and increasing cardiovascular risk. PCSK9 inhibition shows promise in preventing MP-induced endothelial dysfunction via the PCSK9-SIRT6 pathway.

Area of Science:

  • Environmental Health
  • Cardiovascular Research
  • Cellular Biology

Background:

  • Microplastics (MPs) are emerging environmental pollutants linked to increased cardiovascular risk.
  • The molecular mechanisms by which MPs affect vascular endothelial cells remain largely unknown.
  • This study investigates the impact of MPs on endothelial cell function and redox state.

Purpose of the Study:

  • To elucidate the effects of polyethylene (PE) and polyvinyl chloride (PVC) microplastics on human endothelial cells.
  • To investigate the role of proprotein convertase subtilisin-kexin type 9 (PCSK9) and sirtuin 6 (SIRT6) in MP-induced endothelial dysfunction.
  • To evaluate the therapeutic potential of PCSK9 inhibition in mitigating MP-induced vascular damage.

Main Methods:

  • Human endothelial cells (teloHAEC, HUVEC, HCAEC) were exposed to PE and PVC microplastics.
  • Cell viability, endothelial function, mitochondrial metabolism, and inflammatory markers were assessed.
  • PCSK9 and SIRT6 expression levels were quantified; PCSK9 inhibition was evaluated using evolocumab.

Main Results:

  • MPs upregulated inflammatory mediators (MCP-1, VCAM1, ICAM1) and promoted apoptosis and cell cycle arrest.
  • MP exposure impaired mitochondrial respiration, increased reactive oxygen species (ROS), downregulated SIRT6, and upregulated PCSK9.
  • PCSK9 inhibition with evolocumab ameliorated MP-induced endothelial dysfunction, partly via SIRT6 modulation.

Conclusions:

  • Microplastic exposure induces endothelial dysfunction through mechanisms involving PCSK9 and SIRT6.
  • PCSK9 inhibition represents a potential therapeutic strategy to counteract the cardiovascular risks associated with microplastic pollution.
  • The PCSK9-SIRT6 axis is identified as a novel target for preventing microplastic-induced endothelial damage.